Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22425702 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety, PK and Efficacy of 15 Days of SCY-635 Treatment in Hepatitis C Patients
Condition: Chronic Hepatitis C
Interventions: Drug: Placebo;   Drug: SCY-635

Indicates status has not been verified in more than two years